1. Home
  2. NX vs XNCR Comparison

NX vs XNCR Comparison

Compare NX & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanex Building Products Corporation

NX

Quanex Building Products Corporation

HOLD

Current Price

$20.35

Market Cap

939.3M

Sector

Industrials

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$12.01

Market Cap

881.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NX
XNCR
Founded
1927
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
939.3M
881.9M
IPO Year
2008
2013

Fundamental Metrics

Financial Performance
Metric
NX
XNCR
Price
$20.35
$12.01
Analyst Decision
Strong Buy
Buy
Analyst Count
1
9
Target Price
$28.00
$22.33
AVG Volume (30 Days)
325.3K
682.7K
Earning Date
06-04-2026
05-08-2026
Dividend Yield
1.55%
N/A
EPS Growth
N/A
65.36
EPS
N/A
N/A
Revenue
$1,837,641,000.00
$125,576,000.00
Revenue This Year
$4.26
N/A
Revenue Next Year
$1.77
$4.80
P/E Ratio
N/A
N/A
Revenue Growth
43.81
13.65
52 Week Low
$11.04
$6.92
52 Week High
$22.90
$18.69

Technical Indicators

Market Signals
Indicator
NX
XNCR
Relative Strength Index (RSI) 58.46 45.32
Support Level $18.08 $10.93
Resistance Level $22.64 $12.87
Average True Range (ATR) 0.81 0.70
MACD 0.10 -0.02
Stochastic Oscillator 62.94 7.19

Price Performance

Historical Comparison
NX
XNCR

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Share on Social Networks: